Botanical species · safety record

Morus nigra

The EFSA Compendium of Botanicals holds 11 constituent measurements and 2 adverse-effect records for Morus nigra. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Morus nigra L.

11Constituent measurements
2Safety records
8Cited sources
2Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 2 licensed products naming Morus nigra as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Fresh

Source material stated

  • Buds

What the records describe

Constituents measured

  • Lectins2
  • 4-hydroxybenzoic acid1
  • Alkaloids1
  • Cardiac glycosides1
  • Gallic acid1
  • P-coumaric acid1
  • Salicylic acid1
  • Saponins1
  • Scopoletin1
  • Umbelliferone1

Plant parts

  • Fruit unspecified7
  • Live plants3
  • Leaves2
  • Bark1

Preparations

  • Solvent extraction10
  • Fermentation3

Effect types

  • Digestive2

Target tissues

  • Digestive2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsFruit unspecifiedSolvent extractionPhytochemical screeningResolve DOI
Cardiac glycosidesFruit unspecifiedSolvent extractionPhytochemical screeningResolve DOI
LectinsBarkSolvent extractionChromatographic testsResolve DOI
LectinsLive plantsSolvent extractionUnspecifiedResolve DOI
Salicylic acidFruit unspecifiedSolvent extractionGC-MSResolve DOI
SaponinsFruit unspecifiedSolvent extractionPhytochemical screeningResolve DOI
4-hydroxybenzoic acidFruit unspecifiedFermentationHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gallic acidFruit unspecifiedFermentationHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
P-coumaric acidFruit unspecifiedFermentationHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
ScopoletinLive plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
UmbelliferoneLive plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveLeavesSolvent extractionIn vitroNo resolvable identifier
DigestiveDigestiveLeavesSolvent extractionIn vitroNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Kalkan Yildirim, Hatice. Assessing wines based on total phenols, phenolic acids and chemometrics by multivariate analyses. African Journal of Biotechnology, 2013, p. 3563-3569.
  2. Singh, Tanuja., Wu, June H., Peumans, Willy J., Rouge, Pierre., Van Damme, Els J. M., Wu, Albert M. Recognition profile of Morus nigra agglutinin (Morniga G) expressed by monomeric ligands, simple clusters and mammalian polyvalent glycotopes . Molecular immunology, 2007, vol. 44, no. 4, p. 451-462. DOI
  3. Ma, Q.-H. Monocot chimeric jacalins: A novel subfamily of plant lectins. Critical reviews in biotechnology, 2014, vol. 34, no. 4, p. 300-306. DOI
  4. Malik, M.N.H., Alamgeer., Salma, U., Qayyum, A., Samreen, S. Phytochemical analysis and cardiac depressant activity of aqueous methanolic extract of morus nigra l. fruit.. Journal of Applied Pharmaceutical Science, 2012, vol. 2, no. 12, p. 39-41. DOI
  5. El-Tawil, B. A., Ashy, M. A., Tawfik, N. I., Khalil, A. M., Bahafi, S. O. Constituents of local plants. Part 6: The constituents of Morus nigra L. plants. Pharmazie, 1980, p. 35(5-356).
  6. Wang, Lin-Ling., Zhou, Ze-Yang. Effect of extracts of mulberry leaves processed differently on the activity of alpha-glucosidase. Journal of food, agriculture environment, 2008, p. 86-89.
  7. Nickavar, Bahman., Mosazadeh, Golboo. Influence of Three Morus Species Extracts on alpha-Amylase Activity. Iranian journal of pharmaceutical research, 2009, vol. 8, no. 2, p. 115-119.
  8. Zadernowski, R., Naczk, M., Nesterowicz, J. Phenolic acid profiles in some small berries. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2005, vol. 53, no. 6, p. 2118-2124. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue